An IVF (in vitro fertilisation) services provider reports a sharp decline in net profit, attributing the result to fewer women starting new treatment cycles. The company also says it is working to improve performance despite the lower take-up of treatments.
The outlets agree that the profit drop is linked to a reduction in the number of new cycles commenced, rather than a different primary driver. While the reports focus on the downturn in new cycle starts, they also include a note from the provider that conditions in the business are improving. Both sources present the same overall picture: fewer new treatment commencements lead to weaker financial results in the reporting period, followed by signs that the company expects or is seeing improvement.
